Rapid Responses to:

REVIEWS: Ray Moynihan Fix for low sex drive puts reporters in a bad patch BMJ 2004; 329: 1294 [Full text]

Rapid Responses: Submit a response to this article

Rapid Responses published:

New Scientist did declare drug company funding

Damian Carrington   (7 December 2004)

New Scientist did declare drug company funding 7 December 2004
Damian Carrington, Online Editor, New Scientist Lacon House, 84 Theobald's Road, London, WC1X 8NS Send response to journal: Re: New Scientist did declare drug company funding	Ray Moynihan's article (vol 329, p 1294) gives an incorrect impression of our coverage of testosterone patches. He sets out a number of substantial charges but does not detail which of the several stories he mentions fall down in his opinion on which charge. As a consequence, all the stories mentioned appear to have failed on all counts. This is far from the case. For example, there is no mention that the New Scientist story states clearly that the research was sponsored by Proctor and Gamble and that it identifies the narrow patient group studied. We are happy to be held accountable for any perceived inadequacies in our reporting, but to have this done in misleading fashion is highly ironic. Competing interests: None declared